Literature DB >> 25552680

RNA sequencing reveals a unique fusion of the lysine (K)-specific methyltransferase 2A and smooth muscle myosin heavy chain 11 in myelodysplastic syndrome and acute myeloid leukemia.

Mathijs A Sanders1, François G Kavelaars1, Annelieke Zeilemaker1, Adil S A Al Hinai1, Saman Abbas1, H Berna Beverloo1, Kirsten van Lom1, Peter J M Valk2.   

Abstract

Entities:  

Keywords:  KMT2A; MYH11; acute myeloid leukemia; mutations; myelodysplastic syndrome

Mesh：

Substances：

Year:  2015        PMID： 25552680      PMCID： PMC4281319          DOI： 10.3324/haematol.2014.110775

Source DB:  PubMed          Journal:  Haematologica        ISSN： 0390-6078            Impact factor:   9.941


× No keyword cloud information.
  16 in total

1.  All patients with the T(11;16)(q23;p13.3) that involves MLL and CBP have treatment-related hematologic disorders.

Authors:  J D Rowley; S Reshmi; O Sobulo; T Musvee; J Anastasi; S Raimondi; N R Schneider; J C Barredo; E S Cantu; B Schlegelberger; F Behm; N A Doggett; J Borrow; N Zeleznik-Le
Journal:  Blood       Date:  1997-07-15       Impact factor: 22.113

2.  Prediction of molecular subtypes in acute myeloid leukemia based on gene expression profiling.

Authors:  Roel G W Verhaak; Bas J Wouters; Claudia A J Erpelinck; Saman Abbas; H Berna Beverloo; Sanne Lugthart; Bob Löwenberg; Ruud Delwel; Peter J M Valk
Journal:  Haematologica       Date:  2008-10-06       Impact factor: 9.941

3.  The t(11;16)(q23;p13) translocation in myelodysplastic syndrome fuses the MLL gene to the CBP gene.

Authors:  T Taki; M Sako; M Tsuchida; Y Hayashi
Journal:  Blood       Date:  1997-06-01       Impact factor: 22.113

Review 4.  Molecular genetics of adult acute myeloid leukemia: prognostic and therapeutic implications.

Authors:  Guido Marcucci; Torsten Haferlach; Hartmut Döhner
Journal:  J Clin Oncol       Date:  2011-01-10       Impact factor: 44.544

Review 5.  Standardized RT-PCR analysis of fusion gene transcripts from chromosome aberrations in acute leukemia for detection of minimal residual disease. Report of the BIOMED-1 Concerted Action: investigation of minimal residual disease in acute leukemia.

Authors:  J J van Dongen; E A Macintyre; J A Gabert; E Delabesse; V Rossi; G Saglio; E Gottardi; A Rambaldi; G Dotti; F Griesinger; A Parreira; P Gameiro; M G Diáz; M Malec; A W Langerak; J F San Miguel; A Biondi
Journal:  Leukemia       Date:  1999-12       Impact factor: 11.528

6.  Prognostically useful gene-expression profiles in acute myeloid leukemia.

Authors:  Peter J M Valk; Roel G W Verhaak; M Antoinette Beijen; Claudia A J Erpelinck; Sahar Barjesteh van Waalwijk van Doorn-Khosrovani; Judith M Boer; H Berna Beverloo; Michael J Moorhouse; Peter J van der Spek; Bob Löwenberg; Ruud Delwel
Journal:  N Engl J Med       Date:  2004-04-15       Impact factor: 91.245

Review 7.  MLL translocations, histone modifications and leukaemia stem-cell development.

Authors:  Andrei V Krivtsov; Scott A Armstrong
Journal:  Nat Rev Cancer       Date:  2007-11       Impact factor: 60.716

8.  New insights to the MLL recombinome of acute leukemias.

Authors:  C Meyer; E Kowarz; J Hofmann; A Renneville; J Zuna; J Trka; R Ben Abdelali; E Macintyre; E De Braekeleer; M De Braekeleer; E Delabesse; M P de Oliveira; H Cavé; E Clappier; J J M van Dongen; B V Balgobind; M M van den Heuvel-Eibrink; H B Beverloo; R Panzer-Grümayer; A Teigler-Schlegel; J Harbott; E Kjeldsen; S Schnittger; U Koehl; B Gruhn; O Heidenreich; L C Chan; S F Yip; M Krzywinski; C Eckert; A Möricke; M Schrappe; C N Alonso; B W Schäfer; J Krauter; D A Lee; U Zur Stadt; G Te Kronnie; R Sutton; S Izraeli; L Trakhtenbrot; L Lo Nigro; G Tsaur; L Fechina; T Szczepanski; S Strehl; D Ilencikova; M Molkentin; T Burmeister; T Dingermann; T Klingebiel; R Marschalek
Journal:  Leukemia       Date:  2009-03-05       Impact factor: 11.528

9.  Integrative genomics viewer.

Authors:  James T Robinson; Helga Thorvaldsdóttir; Wendy Winckler; Mitchell Guttman; Eric S Lander; Gad Getz; Jill P Mesirov
Journal:  Nat Biotechnol       Date:  2011-01       Impact factor: 54.908

10.  TopHat2: accurate alignment of transcriptomes in the presence of insertions, deletions and gene fusions.

Authors:  Daehwan Kim; Geo Pertea; Cole Trapnell; Harold Pimentel; Ryan Kelley; Steven L Salzberg
Journal:  Genome Biol       Date:  2013-04-25       Impact factor: 13.583
View more
  1 in total

1.  Genomic and transcriptomic profiling of resistant CEM/ADR-5000 and sensitive CCRF-CEM leukaemia cells for unravelling the full complexity of multi-factorial multidrug resistance.

Authors:  Onat Kadioglu; Jingming Cao; Nadezda Kosyakova; Kristin Mrasek; Thomas Liehr; Thomas Efferth
Journal:  Sci Rep       Date:  2016-11-08       Impact factor: 4.379
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.